术前口服多糖溶液对结直肠癌患者术后胰岛素抵抗的关联性研究

doi:10.6040/j.issn.1671-7554.0.2019.527

摘要/Abstract

摘要： 目的通过对比择期结直肠癌患者术前口服多糖溶液及安慰剂的术后胰岛素抵抗及并发症情况,探讨其安全性、可行性及优势。方法将2017年4月至2018年12月哈尔滨医科大学附属第二医院普外科的病历资料进行回顾分析,80例结直肠癌患者包括多糖溶液组40例与对照组(安慰剂组)40例。比较两组患者的一般资料、稳态模型2胰岛素抵抗指数(HOMA2-IR)、稳态模型2胰岛素敏感指数(HOMA2-%S)、空腹血糖(FPG)、空腹胰岛素(FINS)、白细胞计数(WBC)、C反应蛋白(CRP)、降钙素原(PCT)、术后并发症等情况,并进行统计学分析。结果 (1)两组患者的一般资料差异无统计学意义,术中均未出现误吸。(2)两组患者术后FPG、FINS、HOMA2-IR均较术前升高,HOMA2-%S降低(P<0.05)。(3)多糖溶液组患者术后第1、3天的空腹血糖、空腹胰岛素、胰岛素抵抗指数小于对照组,胰岛素敏感指数高于对照组(P<0.05)。(4)多糖溶液组患者术后白细胞、C反应蛋白较对照组低(P<0.05)。(5)多糖溶液组患者术后首次排气时间早于对照组(P<0.05)。(6)两组患者在术后感染性并发症、住院时间、住院费用方面差异无统计学意义(P>0.05)。结论与对照组相比,术前口服多糖溶液不增加误吸风险,而且能显著降低术后胰岛素抵抗、增加胰岛素敏感性、促进肠道功能恢复,但是在住院时间、住院费用及并发症方面并无明显差异。

关键词: 多糖溶液, 碳水化合物, 结直肠癌, 胰岛素抵抗, 并发症

Abstract: Objective To explore the safety, feasibility and advantages of preoperative oral polysaccharide solution by comparing postoperative insulin resistance and complications between preoperative oral polysaccharide solution and placebo for patients undertaking elective colorectal surgery. Methods The clinical data of 80 patients with colorectal cancer treated during Apr. 2017 and Dec. 2018 were retrospectively analyzed, including 40 patients in the polysaccharide solution group and 40 in the control group(placebo group). The general data, homeostasis model assessment-2 insulin resistance index(HOMA2-IR), homeostasis model assessment-2 insulin sensitivity index(HOMA2-%S), fasting plasma glucose(FPG), fasting insulin(FINS), white blood cell count(WBC), C-reactive protein(CRP), procalcitonin(PCT), and postoperative complications were compared between the two groups. Results (1) There were no statistical differences in the general data between the two groups and no aspiration occurred during operation. (2) The FPG, FINS and HOMA2-IR of both groups increased after operation, while HOMA2-%S decreased(P<0.05). (3) The polysaccharide solution group had lower FPS, FINS and HOMA2-IR but higher HOMA2-%S on the 1^st and 3^rd postoperative day(POD1, POD3)than the control group(P<0.05). (4) The polysaccharide solution group had lower postoperative WBC 山东大学学报 (医学版)57卷9期 -吴成威,等.术前口服多糖溶液对结直肠癌患者术后胰岛素抵抗的关联性研究 \=-and CRP(P<0.05). (5) The polysaccharide solution group had shorter first anus exhausting time(P<0.05). (6) There were no significant differences in postoperative infectious complications, length of stay(LOS)and hospitalization costs between the two groups(P>0.05). Conclusion Compared with the placebo, preoperative oral polysaccharide solution does not increase the risk of aspiration. Instead, it significantly reduces insulin resistance, increases insulin sensitivity, and promotes the recovery of intestinal function. However, there are no significant differences in the length of stay, hospitalization costs and complications between the usage of placebo and polysaccharide solution.

Key words: Polysaccharide solution, Carbohydrate, Colorectal cancer, Insulin resistance, Complications

中图分类号:

R656

吴成威,孙博实,周军德,蒋天明,迟强. 术前口服多糖溶液对结直肠癌患者术后胰岛素抵抗的关联性研究[J]. 山东大学学报 (医学版), 2019, 57(9): 48-53.

WU Chengwei, SUN Boshi, ZHOU Junde, JIANG Tianming, CHI Qiang. Association between preoperative oral polysaccharide solution and insulin resistance in patients with colorectal cancer[J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 48-53.

参考文献

[1] Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia[J]. Am J Obstet Gynecol, 1946, 52: 191-205.
[2] Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery[J]. Br J Surg, 1994, 81(1): 59-63.
[3] Thorell A, Efendic S, Gutniak M, et al. Development of postoperative insulin resistance is associated with the magnitude of operation[J]. Eur J Surg, 1993, 159(11-12): 593-599.
[4] Nygren J, Thorell A, Ljungqvist O. Preoperative oral carbohydrate therapy[J]. Curr Opin Anaesthesiol, 2015, 28(3): 364-369.
[5] Çakar E, Yilmaz E, Çakar E, et al. The effect of preoperative oral carbohydrate solution intake on patient comfort: a randomized controlled study[J]. J Perianesth Nurs, 2017, 32(6): 589-599.
[6] Tudor-Drobjewski BA, Marhofer P, Kimberger O, et al. Randomised controlled trial comparing preoperative carbohydrate loading with standard fasting in paediatric anaesthesia[J]. Br J Anaesth, 2018, 121(3): 656-661.
[7] Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation[J]. Br J Anaesth, 1997, 78(5): 606-617.
[8] 陈凛, 陈亚进, 董海龙, 等. 加速康复外科中国专家共识及路径管理指南(2018版)[J]. 中国实用外科杂志, 2018, 38(1): 1-20.
[9] Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery(ERAS)society recommendations: 2018[J]. World J Surg, 2019, 43(3): 659-695.
[10] 郭晶, 邬维娜, 蔡学联, 等. 医务人员禁食禁饮方案实践指南的认知及依从现状调查[J]. 中华现代护理杂志, 2017, 23(35): 4460-4464. GUO Jing, WU Weina, CAI Xuelian, et al. Cognition and compliance of medical staff on fasting and water deprivation scheme from practice guideline[J]. Chinese Journal of Modern Nursing, 2017, 23(35): 4460-4464.
[11] 孙志坚, 孙旭, 孙伟桐, 等. 我国创伤骨科医生围手术期饮食管理现状调查[J]. 中华创伤骨科杂志, 2018, 20(8): 683-688. SUN Zhijian, SUN Xu, SUN Weitong, et al. Perioperative fasting management by traumatic surgeons in China[J]. Chinese Journal of Orthopaedic Trauma, 2018, 20(8): 683-688.
[12] Falconer R, Skouras C, Carter T, et al. Preoperative fasting: current practice and areas for improvement[J]. Updates Surg, 2014, 66(1): 31-39.
[13] Worknehe A, Ambrose R, Alula BN, et al. Preoperative fasting times in elective surgical patients at a referral Hospital in Botswana[J]. Pan Afr Med J, 2016, 23:102. doi: 10.11604/pamj.2016.23.102.8863.
[14] Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress[J]. Curr Opin Clin Nutr Metab Care, 1999, 2(1): 69-78.
[15] Shohat N, Muhsen K, Gilat R, et al. Inadequate glycemic control is associated with increased surgical site infection in total joint arthroplasty: a systematic review and meta-analysis[J]. J Arthroplasty, 2018, 33(7): 2312-2321.
[16] Wang Y, Hu S, Ying H, et al. Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis[J]. BMC Endocr Disord, 2018, 18(1): 42. doi: 10.1186/s12902-018-0268-9.
[17] Lachmann G, Wollersheim T, Spies C. Severe perioperative hyperglycemia attenuates postoperative monocytic function, basophil count and T cell activation[J]. Minerva Anestesiol, 2017, 83(9): 921-929.
[18] Mraovic B, Suh D, Jacovides C, et al. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty[J]. J Diabetes Sci Technol, 2011, 5(2): 412-418.
[19] Mesotten D, Preiser JC, Kosiborod M. Glucose management in critically ill adults and children[J]. Lancet Diabetes Endocrinol, 2015, 3(9): 723-733.
[20] Gianotti L, Biffi R, Sandini M, et al. Preoperative oral carbohydrate load versus placebo in major elective abdominal surgery(PROCY): a randomized, placebo-controlled, multicenter, phase III trial[J]. Ann Surg, 2018, 267(4): 623-630.
[21] Gustafsson UO, Nygren J, Thorell A, et al. Pre-operative carbohydrate loading may be used in type 2 diabetes patients[J]. Acta Anaesthesiol Scand, 2008, 52(7): 946-951.
[22] Näveri H, Tikkanen H, Kairento AL, et al. Gastric emptying and serum insulin levels after intake of glucose-polymer solutions[J]. Eur J Appl Physiol Occup Physiol, 1989, 58(6): 661-665.
[23] Esaki K, Tsukamoto M, Sakamoto E, et al. Effects of preoperative oral carbohydrate therapy on perioperative glucose metabolism during oral-maxillofacial surgery: randomised clinical trial[J]. Asia Pac J Clin Nutr, 2018, 27(1): 137-143.
[24] Thiele RH, Raghunathan K, Brudney CS, et al. American society for enhanced recovery(ASER)and perioperative quality initiative(POQI)joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery[J]. Perioper Med, 2016, 5(1): 24. doi: 10.1186/s13741-016-0049-9.
[25] Nygren J, Thorell A, Jacobsson H, et al. Preoperative gastric emptying. Effects of anxiety and oral carbohydrate administration [J]. Ann Surg, 1995, 222(6): 728-734.

相关文章 15

[1]	张媛李英敏冯月秋常彩云潘华伟王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[2]	董恣豪,刘喆,王浩,于辰曦,杨光,丰浩田. 髋关节镜下关节囊不同切开方式早期术后并发症[J]. 山东大学学报 (医学版), 2026, 64(5): 83-87.
[3]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[4]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[5]	王刚,徐鹏演,赵旭安,王海锋,葛苗苗,潘华峰,江志伟. ω-3多不饱和脂肪酸对腹腔镜结直肠癌术后迷走神经和肠功能恢复的影响[J]. 山东大学学报 (医学版), 2025, 63(2): 36-42.
[6]	崔倩倩,李金鹏,吴豫丹,侯志平,孙玮螺,崔盼盼,何培元. 粪便miRNA对结直肠进展期腺瘤无创筛查的临床价值[J]. 山东大学学报 (医学版), 2025, 63(2): 43-50.
[7]	常宇,胡云峰,王会丰,郭静,张跳,郝雅琴,刘雨. 阑尾切除术与结直肠癌发病风险关联的孟德尔随机化研究[J]. 山东大学学报 (医学版), 2025, 63(2): 77-83.
[8]	俞静,王刚,王烨,邵明月,潘华峰,葛苗苗,王海锋,江志伟. 基于I-FEED评分系统观察益气导滞方对结直肠癌术后胃肠功能恢复的影响[J]. 山东大学学报 (医学版), 2025, 63(12): 35-43.
[9]	史潇兮,辛世杰. 腹主动脉瘤的开放手术[J]. 山东大学学报 (医学版), 2024, 62(9): 26-29.
[10]	刘淋,王晓楠,杨雅溪,王江腾,李旭,周新丽,管庆波,张栩. 甘油三酯-葡萄糖指数与颅内动脉粥样硬化性狭窄的相关性[J]. 山东大学学报 (医学版), 2024, 62(8): 93-100.
[11]	王潇,孔文茹,崔伟亮,王姝麒. 羊角棉总生物碱增强氟尿嘧啶对结直肠癌化疗敏感性[J]. 山东大学学报 (医学版), 2024, 62(6): 30-37.
[12]	魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[13]	刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[14]	许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111.
[15]	王瑞霞,苏童,赵淑磊. 内镜逆行性胆胰管造影术罕见并发症-胆道支架无法拔除1例[J]. 山东大学学报 (医学版), 2024, 62(2): 113-115.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed